Updated lung cancer staging system
- PMID: 20001795
- DOI: 10.2217/fon.09.131
Updated lung cancer staging system
Abstract
The tumor, node and metastasis classification of malignant tumors is periodically revised. Its seventh edition includes the updated classification for lung cancer, based on the analyses of the International Association for the Study of Lung Cancer international database. It is the largest validation ever carried out to date: 100,869 patients registered in 46 databases from 20 countries. The analysis of this database allowed a detailed study of the impact of tumor size on prognosis, the reclassification of additional tumor nodules, the reclassification of pleural dissemination and the separation of two groups of metastatic disease. These changes led to modifications in stage grouping that better differentiate tumors with different prognosis. This updated classification is also recommended for small-cell lung cancer, and for broncho-pulmonary carcinoids. A new international nodal map with stations and zones, and a histological definition of visceral pleura invasion, have also been proposed.
Similar articles
-
The new tumor, node, and metastasis staging system.Semin Respir Crit Care Med. 2011 Feb;32(1):44-51. doi: 10.1055/s-0031-1272868. Epub 2011 Apr 15. Semin Respir Crit Care Med. 2011. PMID: 21500123
-
The revised TNM staging system for lung cancer.Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):4-9. Ann Thorac Cardiovasc Surg. 2009. PMID: 19262443 Review.
-
An update on lung cancer staging.Adv Anat Pathol. 2010 Jan;17(1):33-7. doi: 10.1097/PAP.0b013e3181c66f15. Adv Anat Pathol. 2010. PMID: 20032636 Review.
-
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.J Thorac Oncol. 2007 Dec;2(12):1067-77. doi: 10.1097/JTO.0b013e31815bdc0d. J Thorac Oncol. 2007. PMID: 18090577
-
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.J Thorac Oncol. 2008 Nov;3(11):1213-23. doi: 10.1097/JTO.0b013e31818b06e3. J Thorac Oncol. 2008. PMID: 18978555
Cited by
-
A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.J Thorac Oncol. 2010 Nov;5(11):1821-5. doi: 10.1097/JTO.0b013e3181f1d23c. J Thorac Oncol. 2010. PMID: 20881641 Free PMC article. Clinical Trial.
-
Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.Transl Lung Cancer Res. 2015 Aug;4(4):415-23. doi: 10.3978/j.issn.2218-6751.2015.07.11. Transl Lung Cancer Res. 2015. PMID: 26380182 Free PMC article.
-
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.BMC Clin Pathol. 2014 Feb 13;14(1):9. doi: 10.1186/1472-6890-14-9. BMC Clin Pathol. 2014. PMID: 24524655 Free PMC article.
-
CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.Neoplasia. 2015 Nov;17(11):839-48. doi: 10.1016/j.neo.2015.11.004. Neoplasia. 2015. PMID: 26678911 Free PMC article.
-
Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.J Thorac Dis. 2016 May;8(5):894-900. doi: 10.21037/jtd.2016.03.51. J Thorac Dis. 2016. PMID: 27162664 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical